Yes you stay in control
FGF21 decreases body weight without reducing food intake or bone mineral density in high-fat fed obese rhesus macaque monkeys
A second pivotal phase 3 trial of CagriSema, which enrolled adults with type 2 diabetes and either obesity or overweight, is expected to report data in the first half of 2025
A study looking at what happens when you stop weight loss treatment found that people often return to their starting weight in 1.7 years after stopping semaglutide and tirzepatide (the active ingredient in Mounjaro)
The IHE-DCM is an easy to use, transparent, and externally validated [19, 20] Excel-based model which has an established international history of being used for reimbursement decisions associated with HTA submissions in T2D [21,22,23,24,25]
Due to possible side effects like nausea, vomiting, diarrhea and dizziness or other more serious reactions